"Helen Knight, director of medicines evaluation at NICE, says she is pleased a "commercial solution" means the treatment can be made available on the NHS in England but adds she knows the decision "comes too late for many families".
"Our role is important in ensuring NHS spending on new medicines reflects the benefits they deliver while protecting valuable health resources for other essential patient services," she says."
Framing: assertive ·
First seen: 2026-09-17 ·
Last seen: 2026-09-17 ·
Spread: 1 articles
The Aporia